EFFICACY AND SAFETY OF ABP 798 COMPARED WITH RITUXIMAB: RESULTS FROM THE COMPARATIVE CLINICAL STUDY IN PATIENTS WITH NON-HODGKIN’S LYMPHOMA
EHA Library, David Chien, 298099
18F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY VERSUS BONE MARROW BIOPSY FOR THE EVALUATION OF BONE MARROW INFILTRATION IN NEWLY DIAGNOSED LYMPHOMA PATIENTS: ARE THEY BOTH NECESSARY?
EHA Library, Tania Aguado, 298100
INFORMATIVENESS OF DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING OF THE WHOLE BODY AND POSITRON EMISSION TOMOGRAPHY WITH COMPUTED TOMOGRAPHY FOR FOLLICULAR LYMPHOMA
EHA Library, Ekaterina Nesterova, 298101
ANALYSIS OF THE BONE MARROW INVOLVEMENT IN A GROUP OF PATIENTS WITH FOLLICULAR LYMPHOMA BY COMPARING BONE MARROW BIOPSY AND 18F FDG-PET
EHA Library, Rita S Gomes, 298102
PREVALENCE AND PROGNOSTIC IMPACT OF A POSITIVE SERUM IMMUNOFIXATION IN FOLLICULAR LYMPHOMA PATIENTS
EHA Library, Pablo Mozas, 298103
A MULTI-CENTER RETROSPECTIVE ANALYSIS OF PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AFTER THIRD-LINE CHEMOTHERAPY
EHA Library, Shigeo Fuji, 298104
OBINUTUZUMAB SHORT DURATION INFUSION IN PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA: AN ONGOING STUDY
EHA Library, Kai Hübel, 298105
IS PET-CT USEFUL TO IDENTIFY HISTOLOGICAL TRANSFORMATION IN FOLLICULAR LYMPHOMA? A TWO SPANISH CENTRES EXPERIENCE
EHA Library, Miguel Argüello de Tomás, 298106
ARTIFICIAL INTELLIGENCE AGAINST LYMPHOMA : A NEW DEEP LEARNING BASED ANATOMOPATHOLOGY ASSISTANT TO DISTINGUISH FOLLICULAR LYMPHOMA FROM FOLLICULAR HYPERPLASIA
EHA Library, Camille Laurent, 298107
THE ROLE OF RITUXIMAB MAINTENANCE AFTER FRONTLINE THERAPY FOR FOLLICULAR LYMPHOMA
EHA Library, Dulcelena Pires Neves, 298108
PRETREATMENT SERUM ALBUMIN LEVEL IS ASSOCIATED WITH HIGHER RISK OF PD24 IN LATIN AMERICAN PATIENTS WITH FOLLICULAR LYMPHOMA: A STUDY FROM THE LATIN AMERICAN GROUP OF LYMPHOPROLIFERATIVES (GELL)
EHA Library, Maria Alejandra Torres Viera, 298109
OUTCOME OF A 13-YEARS POPULATION-BASED COHORT OF MANTLE CELL LYMPHOMA PATIENTS: ‘REAL-WORLD’ DATA IDENTIFY SUBGROUPS IN NEED OF NEW THERAPIES.
EHA Library, A. Haven, 298110
HEPATITIS C (HCV)-ASSOCIATED LYMPHOMA MARGINAL ZONE (LMZ) – THE EFFECTIVENESS OF DIFFERENT MODES OF ANTIVIRAL THERAPY (AVT).
EHA Library, sergey lepkov, 298111
CAN THE PROGNOSIS OF MANTLE CELL LYMPHOMA BE PREDICTED BY SIMPLE CBC COUNTS?
EHA Library, Handan Haydaroglu Sahin, 298112
T-CELL LARGE GRANULAR LEUKEMIA WITH ATYPICAL IMMUNOPHENOTYPES: A SINGLE CENTER RETROSPECTIVE ANALYSIS OF 17 CASES
EHA Library, Lei Fan, 298113
BENDAMUSTINE DOSE, TREATMENT CYCLES, AND THE IMPACT OF SOLUBLE IL-2R AND LDH VALUES ON BENDAMUSTINE PLUS RITUXIMAB TREATMENT FOR PATIENTS WITH FOLLICULAR LYMPHOMA
EHA Library, Tatsuro Jo, 298114
EVALUATION OF PATIENTS WITH ADULT ONSET LANGERHANS CELL HISTIOCYTOSIS: A SINGLE CENTER EXPERIENCE
EHA Library, Ali Ünal, 298115
INTENSIVE CHEMO-IMMUNOTHERAPY PLUS HEMATOPOIETIC STEM CELL TRANSPLANTATION OR NON-INTENSIVE TREATMENT FOR MANTLE CELL LYMPHOMA -- REAL WORLD CLINICAL OUTCOME IN SINGLE INSTITUTE EXPERIENCE
EHA Library, Tran-Der Tan, 298116
SUBCUTANEOUS RITUXIMAB WITHOUT SPECIFIC PREMEDICATION IS SAFE AND EFFECTIVE FOR PATIENTS WITH NON-HODGKIN LYMPHOMAS: A SINGLE CENTRE EXPERIENCE
EHA Library, Vasileios Pardalis, 298117
IBRUTINIB IN B-CELL LYMPHOMAS AND CHRONIC GRAFT VERSUS HOST DISEASE: A SINGLE CENTER EXPERIENCE
EHA Library, Aysenur Arslan, 298118
THIRTY-FIVE CASES OF WALDENSTRÖM MACROGLOBULINEMIA: TEN YEARS’ EXPERIENCE FROM A SINGLE CENTER
EHA Library, Silvia García Canale, 298119
PROGNOSTIC SIGNIFICANCE OF ABSOLUTE LYMPHOCYTE TO ABSOLUTE MONOCYTE COUNT RATIO IN EGYPTIAN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA
EHA Library, Asmaa Mohsen, 298120
SERONEGATIVE MYASTHENIA GRAVIS ASSOCIATED WITH WALDENSTROM'S MACROGLOBULINEMIA
EHA Library, Leena Rahmat, 298121
LYMPHOMATOID GRANULOMATOSIS IN AN IMMUNOCOMPETENT WOMAN
EHA Library, Semra Paydas, 298122
HEMATOLOGY EMERGENCY COMPLICATED BY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN INDOLENT LYMPHOMA
EHA Library, D. Rochate, 298123
FOLLICULAR LYMPHOMA DIAGNOSIS AND TREATMENT IN KOSOVO
EHA Library, Edlira Gashi, 298124
TREATMENT OF INDOLENT B LYMPHOMAS WITH RITUXIMAB : A MONOCENTRIC EXPERIENCE
EHA Library, Wala Ben Kridis, 298125
MANTLE CELL LYMPHOMA DIAGNOSIS AND TREATMENT IN KOSOVO
EHA Library, Adriatik Berisha, 298126
THE HEMOGLOBIN, ALBUMIN, LYMPHOCYTE, AND PLATELET (HALP) SCORE IS A NOVEL SIGNIFICANT PROGNOSTIC FACTOR FOR PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA
EHA Library, Vlatka Periša, 298127
R-CHOP CHEMOTHERAPY INCLUDING BIOSIMILAR RITUXIMAB (REDDITUX ®) FOR DE-NOVO DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: REAL LIFE SINGLE CENTER EXPERIENCE
EHA Library, Murat Ozbalak, 298128
FIRST-LINE THERAPY OF ELDERLY PATIENTS WITH DLBCL - A COMPARISON OF PATIENTS TREATED ON THE RICOVER-60 TRIAL AND PATIENTS TREATED WITH R-CEPIVDSP AT BEIJING UNIVERSITY, CHINA
EHA Library, Shenmiao Yang, 298129
THE IMPACT OF OBESITY ON DIFFUSE LARGE B CELL LYMPHOMA PATIENTS TREATED WITH R-CHOP AT PRINCESS NORAH ONCOLOGY CENTER ,NATIONAL GAURD HOSPITAL.JEDDAH,SAUDI ARABIA.
EHA Library, Alhasan Bajawi, 298130
A BURKITT-LIKE FIRST LINE CHEMO-IMMUNOTHERAPY IS HIGHLY EFFECTIVE IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMAS WITH UNFAVOURABLE BIOLOGICAL FEATURES
EHA Library, Lorenzo Manconi, 298131
TREATMENT OF AGGRESSIVE LYMPHOMA IN PREGNANT WOMEN
EHA Library, Yana MANGASAROVA, 298132
MONOCYTE COUNT, LYMPHOCYTE/MONOCYTE RATIO AND RED CELL DISTRIBUTION WIDTH ARE PROGNOSTIC BIOMARKERS IN PERUVIAN PATIENTS WITH AGGRESSIVE T-CELL LYMPHOMAS
EHA Library, Denisse Castro, 298133
PHARMACOKINETIC, PHARMACODYNAMIC, AND CLINICAL ASSESSMENTS USED TO SELECT THE RECOMMENDED PHASE 2 DOSE AND SCHEDULE OF SELINEXOR IN NON-HODGKIN LYMPHOMA (NHL)/DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)
EHA Library, Yosef Landesman, 298134
DEMOGRAPHIC AND CLINICAL OUTCOME OF RELAPSED/ REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN A RESOURCE LIMITED COUNTRY: ANALYSIS OF THE MULTICENTER WEB-BASED REGISTRY FROM THAI LYMPHOMA STUDY GROUP
EHA Library, Archrob Khuhapinant, 298135
TREATMENT OPTIONS AND PROGNOSTIC FACTORS OF EXTRANODAL NK/T CELL LYMPHOMA:A RESTROPECTIVE STUDY
EHA Library, Ting Yang, 298136
HIGHER‐DOSE METHOTREXATE BASED CHEMOTHERAPY REGIMENS BENEFITED PATIENTS WITH UNTREATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A REAL-WORLD STUDY FROM CHINA
EHA Library, Qing Li, 298137
THE PROGNOSTIC ROLE OF CD34 ANGIOGENESIS MARKER IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Svetlana Samarina, 298138
PECAM IS AN EFFECTIVE AND SAFE ANTHRACYCLINE-CONTAINING REGIMEN FOR PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMA.
EHA Library, Fumi Nakamura, 298139
REAL WORLD EFFICACY, TOLERANCE AND RESPONSE TO DOSE ADJUSTMENT OF IMMUNOCHEMOTHERAPY TREATMENT IN ELDERLY AND VERY ELDERLY PATIENTS WITH NON-HODGKIN B LYMPHOMA.
EHA Library, Amalia Domingo-González, 298140
EVALUATION OF FRAILTY SCREENING IN DIFFUSE LARGE B-CELL LYMPHOMA: APPROPRIATE REDUCTION OF CHEMOTHERAPY FOR THE PATIENTS BETWEEN FIT AND FRAIL USING BOTH SUBJECTIVE AND OBJECTIVE EVALUATION
EHA Library, Nana Arai, 298141
NIVOLUMAB-BASED IMMUNOTHERAPY IN RELAPSED/REFRACTORY B-CELL LYMPHOMA, UNCLASSIFIABLE, WITH FEATURES INTERMEDIATE BETWEEN DIFFUSE LARGE B-CELL LYMPHOMA AND CLASSICAL HODGKIN LYMPHOMA
EHA Library, Olesia Smykova, 298142
SAFETY AND EFFICACY OF PET CT DIRECTED RACVBP PROTOCOL FOR THETREATMENT OF DLBCL: EXPERIENCE OF A TERTIARY MEDICAL CENTER INLEBANON
EHA Library, Jean El Cheikh, 298143
BONE MARROW INFILTRATION AS A PROGNOSTIC FACTOR IN PEDIATRIC BURKITT LYMPHOMA PATIENTS
EHA Library, Hany Sayed, 298144
OUTCOMES IN DIFFUSE LARGE B-CELL LYMPHOMA IN THE VERY ELDERLY (>80 YEARS OLD)
EHA Library, Dominic Gordon-Walker, 298145
T CELL NON HODGKIN LYMPHOMA - A TEN YEAR LOOKBACK ON CLINICO-PATHOLOGIC CHARACTERISTICS, TREATMENT STRATEGIES AND OUTCOMES - A SINGLE INSTITUTION EXPERIENCE
EHA Library, Anish Konde, 298146
LENALIDOMIDE AND RITUXIMAB COMBINED WITH CEP CHEMOTHERAPY (R²CEP) FOR PATIENTS WITH RELAPSED B-CELL LYMPHOMA.
EHA Library, Florence Sabirou, 298147
CLINICAL CHARACTERISTICS, PROGNOSTIC FACTORS AND TREATMENT OUTCOMES OF PATIENTS WITH PLASMABLASTIC LYMPHOMA: RETROSPECTIVE ANALYSIS OF KROHEM, THE CROATIAN COOPERATIVE GROUP FOR HEMATOLOGICAL DISEASES
EHA Library, Dino Dujmovic, 298148
POLARGO: RANDOMIZED PHASE III STUDY OF POLATUZUMAB VEDOTIN PLUS RITUXIMAB, GEMCITABINE, AND OXALIPLATIN (R-GEMOX) IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (R/R DLBCL)
EHA Library, Juan-Manuel Sancho, 298149
COMPARISON OF CENTRAL NERVOUS SYSTEM PROPHYLAXIS STRATEGIES AND THEIR THREE YEAR OUTCOMES IN PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA.
EHA Library, Anadil Faqah, 298150
THERAPEUTIC APPROACHES FOR BURKITT LYMPHOMA IN ADOLESCENT AND YOUNG ADULTS POPULATION
EHA Library, Timur Valiev, 298151
PROGNOSTIC VALUE OF PRAME GENE EXPRESSION IN PATIENTS WITH T-CELL LYMPHOMAS
EHA Library, Vsevolod Misyurin, 298152
COMPARISON OF THREE DIFFERENT PROGNOSTIC MODELS IN PATIENTS WITH DE NOVO DIFFUSE LARGE B-CELL LYMPHOMA: SINGLE CENTER RETROSPECTIVE ANALYSIS
EHA Library, Ozan Salim, 298153
CD19-CART (AXICABTAGENE CILOLEUCEL) IN PATIENTS WITH HIGHLY REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA – A SINGLE CENTER EXPERIENCE
EHA Library, Kristina Sohlbach, 298154
ANALYSIS OF THE USE OF DIFFERENT CHEMOTHERAPY REGIMENS IN THE TREATMENT OF PATIENTS WITH RELAPSE AND REFRACTORY DLBCL IN REAL PRACTICE (UKRAINIAN RETROSPECTIVE STUDY)
EHA Library, Iryna Tytorenko, 298155
OUTCOMES OF CENTRAL NERVOUS SYSTEM PROPHYLAXIS WITH SYSTEMIC HIGH DOSE METHOTREXATE IN DIFFUSE LARGE B-CELL LYMPHOMA IN A DISTRICT GENERAL HOSPITAL
EHA Library, Dale Seviar, 298156
SINGLE ARM TRIAL OF BENDAMUSTINE IN COMBINATION WITH RITUXIMAB FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN JAPAN
EHA Library, Toru Kiguchi, 298157
PRIMARY EXTRANODAL NON-HODGKIN'S LYMPHOMA: CLINICOPATHOLOGICAL FEATURES, SURVIVAL AND TREATMENT OUTCOME IN HEMATOLOGY CLINIC OF CRAIOVA, ROMANIA
EHA Library, Ionela Rotaru, 298158
COMPARISON OF CHOP WITH THP-COP FOR PERIPHERAL T-CELL LYMPHOMA-NOT OTHERWISE SPECIFIED AND ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA.
EHA Library, Shuhei Kida, 298159
A RETROSPECTIVE ANALYSIS OF PERIPHERAL T-CELL LYMPHOMA PATIENTS: SINGLE CENTER ‘REAL-LIFE’ EXPERIENCE
EHA Library, Murat Ozbalak, 298160
SAFETY AND EFFICACY OF DOSE-INTENSIVE CHEMOTHERAPY INCLUDING RITUXIMAB IN THE TREATMENT OF BURKITT’S LYMPHOMA/LEUKEMIA IS INDEPENDENT OF HIV STATUS
EHA Library, Pedro Bettencourt Medeiros, 298161
ACUTE GRAFT-VERSUS-HOST-DISEASE/GRAFT-VERSUS-TUMOR INDUCED BY PEMBROLIZUMAB IN A PATIENT WITH SEZARY SYNDROME RELAPSED AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Giuseppe Petruzzellis, 298162
IDENTIFYING NOVEL PROGNOSTIC MARKERS FOR DIFFUSE LARGE B CELL LYMPHOMA (DLBCL)
EHA Library, Sewa Rijal, 298163
LONG-TERM OUTCOUMES AND PATTERNS OF NOVO EXTRA NODAL DLBCL WITH R-CHOP/21 THERAPY :SINGLE-CENTER SERIES OF 67 CASES FROM ALGÉRIA
EHA Library, Mohamed Sidahmed, 298164
CLINICAL PRESENTATION, TREATMENT MODALITIES AND OUTCOMES OF ADULT PATIENTS WITH BURKITT LYMPHOMA TREATED IN A THIRD-LEVEL CENTER IN MEXICO.
EHA Library, Cynthia Pelayo, 298165
METHOTREXATE PLUS IDARUBICIN IMPROVES OUTCOME OF NEW DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS
EHA Library, Yan Ma, 298166
CLINICAL CHARACTERISTICS AND TREATMENT OUTCOMES OF CHILDREN WITH NON-HODGKIN LYMPHOMA AT A TERTIARY CENTER IN ISTANBUL, TURKEY
EHA Library, Gül Nihal Özdemir, 298167
PRIMARY CUTANEOUS GAMMA-DELTA T-CELL LYMPHOMA: SUCCESSFUL USE OF BRENTUXIMAB VEDOTIN ASSOCIATED WITH CHEMOTHERAPY AS BRIDGING THERAPY TO HAPLOIDENTICAL TRANSPLANT
EHA Library, HARIDIAN DE LA NUEZ MELIAN, 298168
ALK-POSITIVE LARGE B-CELL LYMPHOMA IN CHILDREN: A CASE REPORT AND LITERATURE REVIEW
EHA Library, Yonghong Zhang, 298169
GASTROINTESTINAL PLASMOBLASTIC LYMPHOMA ASSOCIATED WITH WISKOTT-ALDRICH SYNDROME: A CASE REPORT
EHA Library, Ali Ünal, 298170
TREATMENT OUTCOME IN CHILDREN WITH CNS+ BURKITT'S LYMPHOMA USING ONLY INTRATHECAL AND SYSTEM CHEMOTHERAPY COMBINED WITH RITUXIMAB: A SINGLE-CENTER EXPERIENCE FROM BEIJING, CHINA
EHA Library, Shuang Huang, 298171
COMPREHENSIVE GERIATRIC ASSESSMENT (CGA): A SIMPLE TOOL FOR GUIDING THE TREATMENT OF ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN CHINA
EHA Library, Hui Liu, 298172
IMPRINT LYMPH NODE CYTODIAGNOSIS: SINGLE-CENTRE EXPERIENCE.
EHA Library, Alexander Wild, 298173
PROGNOSTIC SIGNIFICANCE OF ABSOLUTE LYMPHOCYTE TO ABSOLUTE MONOCYTE COUNT RATIO IN EGYPTIAN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA
EHA Library, Asmaa Mohsen, 298174
AGGRESSIVE MATURE B CELL LYMPHOMA: CLASSIFICATION ACCORDING TO MORPHOLOGICAL, IMMUNOPHENOTYPICAL AND CYTOGENETIC/MOLECULAR FEATURES IN A SINGLE CENTER IN BRAZIL
EHA Library, Maria De Lourdes Chauffaille, 298175
MONOCLONAL PARAPROTEIN SECRETION IN PATIENTS WITH HIGH-GRADE B-CELL LYMPHOMA DOUBLE-HIT AND NOT OTHERWISE SPECIFIED IS ASSOCIATED WITH CENTRAL NERVOUS SYSTEM AND BONE MARROW INVOLVEMENT
EHA Library, Anna Misyurina, 298176
СLINICAL CASE OF THE DEVELOPMENT OF NON-HODGKIN'S LYMPHOMA IN A PATIENT WITH ESSENTIAL THROMBOCYTHEMIA
EHA Library, Maria Mikhaleva, 298177
EXTRA-NODAL INVOLVEMENT IN DIFFUSE LARGE B-CELL LYMPHOMA: CLINICAL FEATURES
EHA Library, Dorra Jabr, 298178
PRIMARY MEDIASTINAL B CELL LYMPHOMA: HOW DOES THE AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVE THE PROGNOSIS?
EHA Library, Raoudha Mansouri, 298179
RITUXIMAB-BASED THERAPY EFFICIENCY IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN ARMENIA
EHA Library, Melanya Sahakyan, 298180
T CELL LYMPHOMA IN KOSOVO BETWEEN 2009-2019
EHA Library, Viola Cavolli, 298181
PROFILE OF ADVERSE EVENTS OF THE DA-EPOCH-R REGIMEN IN A SOUTH AMERICAN CENTER
EHA Library, Matias Francken, 298182
FOSTAMATINIB FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA
EHA Library, Anna Patrikidou, 298183
PRIMARY NON-HODGKIN'S LYMPHOMA OF THE BONE PRESENTING AS A COMPLETE DISPLACED FRACTURE - A CASE REPORT
EHA Library, Danica Ann Leycano, 298184
PET ORIENTED INTENSIFICATION AND MAINTENANCE WITH RITUXIMAB IN FIRST LINE NON-HODGKIN LARGE B CELL LYMPHOMA (DLBCL)
EHA Library, Luca Pezzullo, 298185
A PRECLINICAL STUDY OF IMC-002, A FULLY HUMAN THERAPEUTIC ANTIBODY SAFELY TARGETING CD47 IN CANCER
EHA Library, Hyeon Seok Yoo, 298187
HIGHLY ACCURATE IDENTIFICATION OF LYMPHOMA INVOLVING THE BONE FROM PET/CT REPORTS – AUTOMATED EXTRACTION OF PHENOTYPES FROM CLINICAL TEXT
EHA Library, Anastasia Navitski, 298188
INCREASED SECRETION OF SOLUBLE HLA CLASS 1 MOLECULES BY MULTIPOTENT MESENCHYMAL STROMAL CELLS DERIVED FROM THE BONE MARROW OF DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WITHOUT BONE MARROW INVOLVEMENT
EHA Library, Nataliya Petinati, 298189
PRIMARY VITREORETINAL LYMPHOMA. SINGLE CENTRE EXPERIENCE 2015-2019
EHA Library, Leonor Perez Ortiz, 298190
PROGNOSIS IMPACT OF MYC REARRANGEMENT WITH THE IMMUNOGLOBULIN HEAVY CHAIN GENE T(8;14) IN HIGH-GRADE B DOUBLE-TRIPLE HIT LYMPHOMAS.
EHA Library, Joan Gonzálvez Fernández, 298191
CYTOGENETIC AND MOLECULAR GENETIC ABERRATIONS OF CIITA GENE IN PATIENTS WITH PRIMARY MEDIASTINAL LARGE-CELL B-CELL LYMPHOMA
EHA Library, Svetlana Kuznetsova, 298192
LANGERHANS CELL HISTIOCYTOSIS
EHA Library, Olga Novosad, 298193
18F-FDG PET/CT SCAN IN DETECTING MARROW INVOLVEMENT IN NEWLY DIAGNOSED LYMPHOMA
EHA Library, Ankit Kumar Kumar Jitani, 298194
GENETIC INSTABILITY OF MICROSATELLITE LOCI IN PRYMARY MEDIASTISTINAL B-CELL LYMPHOMA
EHA Library, Yana MANGASAROVA, 298195
HODGKIN-REED-STERNBERG CELLS OF CLASSICAL HODGKIN LYMPHOMA SHOW AN IMPAIRED MOTILITY
EHA Library, Sylvia Hartmann, 298196
PROGNOSTIC VALUE OF PRAME GENE EXPRESSION IN PATIENTS WITH FOLLICULAR LYMPHOMA
EHA Library, Vsevolod Misyurin, 298197
CIRCULATING FREE DNA ANALYSIS IN RUSSIAN PATIENTS WITH PRIMARY MEDIASTINAL LYMPHOMA
EHA Library, Svetlana Smirnova, 298198
COMPARATIVE ASSESSMENT OF SURFACE CD19 AND CD20 EXPRESSION ON B-CELL LYMPHOMAS FROM CLINICAL BIOPSIES. IMPLICATIONS FOR TARGETED THERAPIES.
EHA Library, Rainer Boxhammer, 298199

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings